Motif ID: Osr2_Osr1
Z-value: 0.804
Transcription factors associated with Osr2_Osr1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Osr1 | ENSMUSG00000048387.7 | Osr1 |
Osr2 | ENSMUSG00000022330.4 | Osr2 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Osr1 | mm10_v2_chr12_+_9574437_9574448 | 0.25 | 7.0e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.4 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.8 | 6.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.6 | 1.7 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 1.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.5 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 4.2 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.5 | 2.3 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.4 | 1.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) acetyl-CoA catabolic process(GO:0046356) ketone body catabolic process(GO:0046952) |
0.4 | 6.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 2.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 1.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.3 | 1.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) thermoception(GO:0050955) |
0.3 | 1.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.8 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.8 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.3 | 1.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 1.2 | GO:0036324 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.2 | 1.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 3.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 0.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.2 | 0.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 2.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 1.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.2 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 3.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 2.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 1.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 1.3 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.7 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 1.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 2.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 2.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 1.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.0 | 3.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.4 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 1.1 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.6 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.0 | 4.9 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 2.0 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.6 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.9 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.0 | 1.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.5 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 1.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.5 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.4 | 1.7 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 1.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.3 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 3.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.2 | 6.3 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 3.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 1.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 4.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 5.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 2.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 5.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.3 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 1.7 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
0.4 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 1.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) epinephrine binding(GO:0051379) |
0.4 | 1.2 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.3 | 4.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 2.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 1.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 2.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 1.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 3.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 1.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 4.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.9 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 6.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 2.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.6 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.1 | 4.4 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.1 | 2.3 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.1 | 2.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.1 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.7 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 3.9 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.2 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.0 | 1.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.0 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.0 | 0.4 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.9 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.0 | 1.0 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.0 | 0.1 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.3 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.2 | 3.6 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 0.8 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.6 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.7 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.5 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.2 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.7 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.0 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.6 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 8.2 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.0 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.1 | REACTOME_PLC_BETA_MEDIATED_EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.9 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.5 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.2 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 4.8 | REACTOME_METABOLISM_OF_CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.5 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.3 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 2.1 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.9 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.8 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.0 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |